Related Experiment Videos
Molecular genetics of systemic sclerosis
1Division of Rheumatology and Clinical Immunogenetics, University of Texas Health Science Center at Houston 77225, USA.
Current Opinion in Rheumatology
|November 1, 1995
Summary
Systemic sclerosis (SSc) is linked to specific autoantibody responses associated with the major histocompatibility complex (MHC). Genetic factors, particularly human leukocyte antigen (HLA) alleles, play a crucial role in SSc pathogenesis and clinical manifestations.
Area of Science:
- Immunogenetics
- Rheumatology
- Autoimmune Diseases
Background:
- Systemic sclerosis (SSc) is increasingly understood as a complex autoimmune condition.
- The disease is characterized by autoantibody production linked to specific clinical features.
- Major histocompatibility complex (MHC) associations are central to SSc pathogenesis.
Purpose of the Study:
- To explore the genetic associations of autoantibody responses in systemic sclerosis.
- To identify specific human leukocyte antigen (HLA) alleles involved in SSc.
- To investigate potential genetic factors beyond HLA in SSc development.
Main Methods:
- Analysis of autoantibody specificities in SSc patients.
- Association studies with various HLA alleles (DQB1, DRB1, DPB1).
- Review of established and proposed genetic loci implicated in SSc.
Main Results:
- Anticentromere and anti-topoisomerase I (anti-topo I) antibody responses correlate with specific HLA-DQB1 alleles.
- Anti-topo I responses are also associated with certain HLA-DRB1 alleles.
- Antibodies to PM-Scl and fibrillarin show strong associations with specific HLA haplotypes and alleles (e.g., HLA-DRB1*0301, DQB1*06).
Conclusions:
- HLA alleles are significant genetic factors influencing autoantibody production in SSc.
- Specific HLA associations provide insights into SSc heterogeneity.
- Further research into other genetic loci, such as fibrillin and cytokine genes, is warranted to fully understand SSc pathogenesis.